Health disparities of type 2 diabetes (DM2) in America is an ongoing crisis. Despite this, technology has been helpful in managing DM2 in the non-Hispanic White, Hispanic, and African American populations and has been proven effective. Furthermore, it may be used to supplement health provider DM2 care through telemedicine to lower hemoglobin A1c (A1c), a gold standard DM2 measurement, and other DM2-related outcomes, such as glycated hemoglobin. The purpose of this study was to review current literature on the use of telemedicine in assisting DM2 management in racial ethnic minorities and to discuss how to adjust the telemedicine DM2 management program to be applied to Chinese Americans. In addition, it is worthy to note that the role of nurses makes a substantial difference in the effectiveness of technological management of DM2 from being culturally sensitive and sending catered messages to address specific patient needs.
Li, W., & Zhong, J. (2019). A REVIEW OF TECHNOLOGY-BASED INTERVENTIONS IN IMPROVING TYPE-2-DIABETES MANAGEMENT IN CHINESE AMERICANS. Asian / Pacific Island Nursing Journal, 4(1).